Positively selected sites at HCMV gB furin processing region and their effects in cleavage efficiency

Frontiers in Microbiology

Volumn 8, Issue MAY, 2017, Pages

  Stangherlin, Lucas M ^a   de Paula, F N ^a,b   Icimoto, Marcelo Y ^c   Ruiz, Leonardo G P ^d   Nogueira, Maurício L ^d   Braz, Antônio S K ^a   Juliano, Luiz ^c   da Silva, Maria C C ^a  

^a UNIVERSIDADE FEDERAL DO ABC   (Brazil)

^b Instituto Pasteur de Sao Paulo   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d Sao Jose do Rio Preto Medical School   (Brazil)

Author keywords

Furin cleavage; gB genotypes; Glycoprotein B; Human cytomegalovirus; Selective pressure

Indexed keywords

ALANINE; ARGININE; FURIN; GLYCOPROTEIN B; METHIONINE; THREONINE;

ARTICLE; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DNA EXTRACTION; DNA SEQUENCE; ENZYMATIC ASSAY; GENE AMPLIFICATION; GENE MUTATION; GENOTYPE; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN TISSUE; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; PROTEIN CLEAVAGE; PROTEIN PROCESSING; SEQUENCE ALIGNMENT;

EID: 85019749403     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2017.00934     Document Type: Article

References (89)

1. Bachis, A., Avdoshina, V., Zecca, L., Parsadanian, M., and Mocchetti, I. (2012). Human immunodeficiency virus type 1 alters brain-derived neurotrophic factor processing in neurons. J. Neurosci. 32, 9477-9484. doi: 10.1523/JNEUROSCI.0865-12.2012
2. Boehme, K. W., Guerrero, M., and Compton, T. (2006). Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells. J. Immunol. 177, 7094-7102. doi: 10.4049/jimmunol.177.10.7094
3. Boyle, K. A., and Compton, T. (1998). Receptor-binding properties of a soluble form of human cytomegalovirus glycoprotein B. J. Virol. 72, 1826-1833.
4. Britt, W. J., and Auger, D. (1986). Synthesis and processing of the envelope gp55-116 complex of human cytomegalovirus. J. Virol. 58, 185-191.
5. Britt, W. J., Vugler, L., and Stephens, E. B. (1988). Induction of complement-dependent and -independent neutralizing antibodies by recombinant-derived human cytomegalovirus gp55-116 (gB). J. Virol. 62, 3309-3318.
6. Britt, W. J., and Vugler, L. G. (1989). Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus. J. Virol. 63, 403-410.
7. Britt, W. J., and Vugler, L. G. (1990). Antiviral antibody responses in mothers and their newborn infants with clinical and subclinical congenital cytomegalovirus infections. J. Infect. Dis. 161, 214-219. doi: 10.1093/infdis/161.2.214
8. Burke, H. G., and Heldwein, E. E. (2015). Crystal structure of the human cytomegalovirus glycoprotein B. PLoS Pathog. 11:e1005227. doi: 10.1371/journal.ppat.1005227
9. Cannon, M. J. (2009). Congenital cytomegalovirus (CMV) epidemiology and awareness. J. Clin. Virol. 46, S6-S10. doi: 10.1016/j.jcv.2009.09.002
10. Carraro, E., and Granato, C. F. (2003). Single human cytomegalovirus gB genotype shed in multiple sites at the time of diagnosis in renal transplant recipients. J. Med. Virol. 70, 240-243. doi: 10.1002/jmv.10383
11. Chou, S. (1992). Molecular epidemiology of envelope glycoprotein H of human cytomegalovirus. J. Infect. Dis. 166, 604-607. doi: 10.1093/infdis/166.3.604
12. Chou, S. W., and Dennison, K. M. (1991). Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J. Infect. Dis. 163, 1229-1234. doi: 10.1093/infdis/163.6.1229
13. Coaquette, A., Bourgeois, A., Dirand, C., Varin, A., Chen, W., and Herbein, G. (2004). Mixed cytomegalovirus glycoprotein B genotypes in immunocompromised patients. Clin. Infect. Dis. 39, 155-161. doi: 10.1086/421496
14. Cobbs, C., Khan, S., Matlaf, L., McAllister, S., Zider, A., Yount, G., et al. (2014). HCMV glycoprotein B is expressed in primary glioblastomas and enhances growth and invasiveness via PDGFR-alpha activation. Oncotarget 5, 1091-1100. doi: 10.18632/oncotarget.1787
15. Cunha Ade, A., Marin, L. J., Aquino, V. H., and Figueiredo, L. T. M. (2002). Diagnosis of cytomegalovirus infections by qualitative and quantitative PCR in HIV infected patients. Rev. Inst. Med. Trop. Sa?o Paulo 44, 127-132. doi: 10.1590/S0036-46652002000300003
16. Darriba, D., Taboada, G. L., Doallo, R., and Posada, D. (2012). jModelTest 2: more models, new heuristics and parallel computing. Nat. Methods 9:772. doi: 10.1038/nmeth.2109
17. Deckers, M., Hofmann, J., Kreuzer, K.-A., Reinhard, H., Edubio, A., Hengel, H., et al. (2009). High genotypic diversity and a novel variant of human cytomegalovirus revealed by combined UL33/UL55 genotyping with broad-range PCR. Virol. J. 6, 210. doi: 10.1186/1743-422X-6-210
18. Dziurzynski, K., Chang, S. M., Heimberger, A. B., Kalejta, R. F., Dallas, S. R. M., Smit, M., et al. (2012). Consensus on the role of human cytomegalovirus in glioblastoma. Neuro. Oncol. 14, 246-255. doi: 10.1093/neuonc/nor227
19. Edgar, R. C. (2004). MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32, 1792-1797. doi: 10.1093/nar/gkh340
20. Feire, A. L., Koss, H., and Compton, T. (2004). Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrin-like domain. Proc. Natl. Acad. Sci. U.S.A. 101, 15470-15475. doi: 10.1073/pnas.0406821101
21. Fries, B. C., Chou, S., Boeckh, M., and Torok-Storb, B. (1994). Frequency distribution of cytomegalovirus envelope glycoprotein genotypes in bone marrow transplant recipients. J. Infect. Dis. 169, 769-774. doi: 10.1093/infdis/169.4.769
22. Gaytant, M. A., Steegers, E. A. P., Semmekrot, B. A., Merkus, H. M. M. W., and Galama, J. M. D. (2002). Congenital cytomegalovirus infection: review of the epidemiology and outcome. Obstet. Gynecol. Surv. 57, 245-256. doi: 10.1007/s11940-002-0039-8
23. Glauser, D. L., Milho, R., Frederico, B., May, J. S., Kratz, A.-S., Gillet, L., et al. (2013). Glycoprotein B cleavage is important for murid herpesvirus 4 to infect myeloid cells. J. Virol. 87, 10828-10842. doi: 10.1128/JVI.00709-13
24. Görzer, I., Kerschner, H., Redlberger-Fritz, M., and Puchhammer-Stöckl, E. (2010). Human cytomegalovirus (HCMV) genotype populations in immunocompetent individuals during primary HCMV infection. J. Clin. Virol. 48, 100-103. doi: 10.1016/j.jcv.2010.03.005
25. Guindon, S., Dufayard, J. F., Lefort, V., Anisimova, M., Hordijk, W., and Gascuel, O. (2010). New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst. Biol. 59, 307-321. doi: 10.1093/sysbio/syq010
26. Hall, T. A. (1999). BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 41, 95-98.
27. Hirata, I. Y., Sedenho Cezari, M. H., Nakaie, C. R., Boschcov, P., Ito, A. S., Juliano, M. A., et al. (1995). Internally quenched fluorogenic protease substrates: solid-phase synthesis and fluorescence spectroscopy of peptides containing ortho-aminobenzoyl/dinitrophenyl groups as donor-acceptor pairs. Lett. Pept. Sci. 1, 299-308. doi: 10.1007/BF00119771
28. Isaacson, M. K., and Compton, T. (2009). Human cytomegalovirus glycoprotein B is required for virus entry and cell-to-cell spread but not for virion attachment, assembly, or egress. J. Virol. 83, 3891-3903. doi: 10.1128/JVI.01251-08
29. Isaacson, M. K., Juckem, L. K., and Compton, T. (2008). Virus entry and innate immune activation. Curr. Top. Microbiol. Immunol. 325, 85-100. doi: 10.1007/978-3-540-77349-8_5
30. Izidoro, M. A., Assis, D. M., Oliveira, V., Santos, J. A. N., Juliano, M. A., Lindberg, I., et al. (2010). Effects of magnesium ions on recombinant human furin: selective activation of hydrolytic activity upon substrates derived from virus envelope glycoprotein. Biol. Chem. 391, 1105-1112. doi: 10.1515/BC.2010.114
31. Kacprzak, M. M., Peinado, J. E., Than, M. E., Appel, J., Henrich, S., Lipkind, G., et al. (2004). Inhibition of furin by polyarginine-containing peptides: nanomolar inhibition by nona-D-arginine. J. Biol. Chem. 279, 36788-36794. doi: 10.1074/jbc.M400484200
32. Kopp, A., Blewett, E., Misra, V., and Mettenleiter, T. C. (1994). Proteolytic cleavage of bovine herpesvirus 1 (BHV-1) glycoprotein gB is not necessary for its function in BHV-1 or pseudorabies virus. J. Virol. 68, 1667-1674.
33. Korkmaz, B., Attucci, S., Juliano, M. A., Kalupov, T., Jourdan, M.-L., Juliano, L., et al. (2008). Measuring elastase, proteinase 3 and cathepsin G activities at the surface of human neutrophils with fluorescence resonance energy transfer substrates. Nat. Protoc. 3, 991-1000. doi: 10.1038/nprot.2008.63
34. La Rosa, C., and Diamond, D. J. (2012). The immune response to human CMV. Future Virol. 7, 279-293. doi: 10.2217/fvl.12.8
35. Lurain, N. S., Kapell, K. S., Huang, D. D., Short, J. A., Paintsil, J., Winkfield, E., et al. (1999). Human cytomegalovirus UL144 open reading frame: sequence hypervariability in low-passage clinical isolates. J. Virol. 73, 10040-10050.
36. Macagno, A., Bernasconi, N. L., Vanzetta, F., Dander, E., Sarasini, A., Revello, M. G., et al. (2010). Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex. J. Virol. 84, 1005-1013. doi: 10.1128/JVI.01809-09
37. Madi, N., Al-Nakib, W., Pacsa, A., and Saeed, T. (2011). Cytomegalovirus genotypes gB1 and gH1 are the most predominant genotypes among renal transplant recipients in Kuwait. Transplant. Proc. 43, 1634-1637. doi: 10.1016/j.transproceed.2011.02.053
38. Marshall, G. S., Rabalais, G. P., Stout, G. G., and Waldeyer, S. L. (1992). Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity. J. Infect. Dis. 165, 381-384. doi: 10.1093/infdis/165.2.381
39. Meyer-König, U., Vogelberg, C., Bongarts, A., Kampa, D., Delbrück, R., Wolff-Vorbeck, G., et al. (1998). Glycoprotein B genotype correlates with cell tropism in vivo of human cytomegalovirus infection. J. Med. Virol. 55, 75-81. doi: 10.1002/(SICI)1096-9071(199805)55:175::AID-JMV123.0.CO;2-Z
40. Murrell, B., Wertheim, J. O., Moola, S., Weighill, T., Scheffler, K., Kosakovsky Pond, S. L., et al. (2012). Detecting individual sites subject to episodic diversifying selection. PLoS Genet. 8:e1002764. doi: 10.1371/journal.pgen.1002764
41. Navarro, D., Lennette, E., Tugizov, S., and Pereira, L. (1997). Humoral immune response to functional regions of human cytomegalovirus glycoprotein B. J. Med. Virol. 52, 451-459. doi: 10.1002/(SICI)1096-9071(199708)52:4451::AID-JMV183.0.CO;2-J
42. Navarro, D., Paz, P., Tugizov, S., Topp, K., La Vail, J., and Pereira, L. (1993). Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. Virology 197, 143-158. doi: 10.1006/viro.1993.1575
43. Noriega, V., Redmann, V., Gardner, T., and Tortorella, D. (2012). Diverse immune evasion strategies by human cytomegalovirus. Immunol. Res. 54, 140-151. doi: 10.1007/s12026-012-8304-8
44. Okazaki, K. (2007). Proteolytic cleavage of glycoprotein B is dispensable for in vitro replication, but required for syncytium formation of pseudorabies virus. J. Gen. Virol. 88, 1859-1865. doi: 10.1099/vir.0.82610-0
45. Oliver, S. L., Sommer, M., Zerboni, L., Rajamani, J., Grose, C., and Arvin, A. M. (2009). Mutagenesis of varicella-zoster virus glycoprotein B: putative fusion loop residues are essential for viral replication, and the furin cleavage motif contributes to pathogenesis in skin tissue in vivo. J. Virol. 83, 7495-7506. doi: 10.1128/JVI.00400-09
46. Pang, X., Humar, A., and Preiksaitis, J. K. (2008). Concurrent genotyping and quantitation of cytomegalovirus gB genotypes in solid-organ-transplant recipients by use of a real-time PCR assay. J. Clin. Microbiol. 46, 4004-4010. doi: 10.1128/JCM.01341-08
47. Paradowska, E., Studziñska, M., Nowakowska, D., Wilczyñski, J., Rycel, M., Suski, P., et al. (2012). Distribution of UL144, US28 and UL55 genotypes in Polish newborns with congenital cytomegalovirus infections. Eur. J. Clin. Microbiol. Infect. Dis. 31, 1335-1345. doi: 10.1007/s10096-011-1447-z
48. Pignatelli, S., Dal Monte, P., Rossini, G., and Landini, M. P. (2004). Genetic polymorphisms among human cytomegalovirus (HCMV) wild-type strains. Rev. Med. Virol. 14, 383-410. doi: 10.1002/rmv.438
49. Pond, S. L. K., and Frost, S. D. W. (2005). Datamonkey: rapid detection of selective pressure on individual sites of codon alignments. Bioinformatics 21, 2531-2533. doi: 10.1093/bioinformatics/bti320
50. Potzsch, S., Spindler, N., Wiegers, A. K., Fisch, T., Rucker, P., Sticht, H., et al. (2011). B cell repertoire analysis identifies new antigenic domains on glycoprotein b of human cytomegalovirus which are target of neutralizing antibodies. PLoS Pathog. 7:e1002172. doi: 10.1371/journal.ppat.1002172
51. Powers, C., DeFilippis, V., Malouli, D., and Früh, K. (2008). Cytomegalovirus immune evasion. Curr. Top. Microbiol. Immunol. 325, 333-359. doi: 10.1007/978-3-540-77349-8_19
52. Rasmussen, L., Hong, C., Zipeto, D., Morris, S., Sherman, D., Chou, S., et al. (1997). Cytomegalovirus gB genotype distribution differs in human immunodeficiency virus-infected patients and immunocompromised allograft recipients. J. Infect. Dis. 175, 179-184. doi: 10.1093/infdis/175.1.179
53. Renzette, N., Bhattacharjee, B., Jensen, J. D., Gibson, L., and Kowalik, T. F. (2011). Extensive genome-wide variability of human cytomegalovirus in congenitally infected infants. PLoS Pathog. 7:e1001344. doi: 10.1371/journal.ppat.1001344
54. Renzette, N., Gibson, L., Bhattacharjee, B., Fisher, D., Schleiss, M. R., Jensen, J. D., et al. (2013). Rapid intrahost evolution of human cytomegalovirus is shaped by demography and positive selection. PLoS Genet. 9:e1003735. doi: 10.1371/journal.pgen.1003735
55. Renzette, N., Pokalyuk, C., Gibson, L., Bhattacharjee, B., Schleiss, M. R., Hamprecht, K., et al. (2015). Limits and patterns of cytomegalovirus genomic diversity in humans. Proc. Natl. Acad. Sci. U.S.A. 112, E4120-E4128. doi: 10.1073/pnas.1501880112
56. Ronquist, F., and Huelsenbeck, J. P. (2003). MrBayes 3: Bayesian phylogenetic inference under mixed models. Bioinformatics 19, 1572-1574. doi: 10.1093/bioinformatics/btg180
57. Roubalová, K., Struneckỳ, O., Zufanová, S., Procházka, B., and Vitek, A. (2010). Genotyping of viral glycoprotein B (gB) in hematopoietic stem cell transplant recipients with active cytomegalovirus infection: analysis of the impact of gB genotypes on the patients' outcome. Epidemiol. Mikrobiol. Imunol. 59, 92-99.
58. Sarcinella, L., Mazzulli, T., Willey, B., and Humar, A. (2002). Cytomegalovirus glycoprotein B genotype does not correlate with outcomes in liver transplant patients. J. Clin. Virol. 24, 99-105. doi: 10.1016/S1386-6532(01)00238-4
59. Schechter, I., and Berger, A. (1967). On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27, 157-162. doi: 10.1016/S0006-291X(67)80055-X
60. Sharma, S., Wisner, T. W., Johnson, D. C., and Heldwein, E. E. (2012). HCMV gB shares structural and functional properties with gB proteins from other herpesviruses. Virology 435, 239-249. doi: 10.1016/j.virol.2012.09.024
61. Sharma, S., Wisner, T. W., Johnson, D. C., and Heldwein, E. E. (2013). HCMV gB shares structural and functional properties with gB proteins from other herpesviruses. Virology 435, 239-249. doi: 10.1016/j.virol.2012.09.024
62. Shepp, D. H., Match, M. E., Ashraf, A. B., Lipson, S. M., Millan, C., and Pergolizzi, R. (1996). Cytomegalovirus glycoprotein B groups associated with retinitis in AIDS. J. Infect. Dis. 174, 184-187. doi: 10.1093/infdis/174.1.184
63. Sijmons, S., Van Ranst, M., and Maes, P. (2014). Genomic and functional characteristics of human cytomegalovirus revealed by next-generation sequencing. Viruses 6, 1049-1072. doi: 10.3390/v6031049
64. Soderberg-Naucler, C. (2006). Human cytomegalovirus persists in its host and attacks and avoids elimination by the immune system. Crit. Rev. Immunol. 26, 231-264. doi: 10.1615/CritRevImmunol.v26.i3.30
65. Sorem, J., and Longnecker, R. (2009). Cleavage of Epstein-Barr virus glycoprotein B is required for full function in cell-cell fusion with both epithelial and B cells. J. Gen. Virol. 90, 591-595. doi: 10.1099/vir.0.007237-0
66. Soroceanu, L., Akhavan, A., and Cobbs, C. S. (2008). Platelet-derived growth factor-a receptor activation is required for human cytomegalovirus infection. Nature 455, 391-395. doi: 10.1038/nature07209
67. Soroceanu, L., and Cobbs, C. S. (2011). Is HCMV a tumor promoter? Virus Res. 157, 193-203. doi: 10.1016/j.virusres.2010.10.026
68. Spaete, R. R., Thayer, R. M., Probert, W. S., Masiarz, F. R., Chamberlain, S. H., Rasmussen, L., et al. (1988). Human cytomegalovirus strain Towne glycoprotein B is processed by proteolytic cleavage. Virology 167, 207-225. doi: 10.1016/0042-6822(88)90071-2
69. Spindler, N., Rucker, P., Potzsch, S., Diestel, U., Sticht, H., Martin-Parras, L., et al. (2013). Characterization of a discontinuous neutralizing epitope on glycoprotein B of human cytomegalovirus. J. Virol. 87, 8927-8939. doi: 10.1128/JVI.00434-13
70. Steininger, C. (2007). Clinical relevance of cytomegalovirus infection in patients with disorders of the immune system. Clin. Microbiol. Infect. 13, 953-963. doi: 10.1111/j.1469-0691.2007.01781.x
71. Streblow, D. N., Orloff, S. L., and Nelson, J. A. (2001). Do pathogens accelerate atherosclerosis? J. Nutr. 131, 2798S-2804S.
72. Strive, T., Borst, E., Messerle, M., Radsak, K., Strive, T., Borst, E., et al. (2002). Proteolytic processing of human cytomegalovirus glycoprotein B is dispensable for viral growth in culture. J Virol. 76, 1252-1264. doi: 10.1128/JVI.76.3.1252
73. Tanaka, K., Numazaki, K., and Tsutsumi, H. (2005). Human cytomegalovirus genetic variability in strains isolated from Japanese children during 1983-2003. J. Med. Virol. 76, 356-360. doi: 10.1002/jmv.20366
74. Tarragó, D., Quereda, C., and Tenorio, A. (2003). Different cytomegalovirus glycoprotein B genotype distribution in serum and cerebrospinal fluid specimens determined by a novel multiplex nested PCR. J. Clin. Microbiol. 41, 2872-2877. doi: 10.1128/JCM.41.7.2872-2877.2003
75. Tian, S. (2009). A 20 residues motif delineates the furin cleavage site and its physical properties may influence viral fusion. Biochem. Insights 2, 9-20. doi: 10.4137/BCI.S2049
76. Trincado, D. E., Scott, G. M., White, P. A., Hunt, C., Rasmussen, L., and Rawlinson, W. D. (2000). Human cytomegalovirus strains associated with congenital and perinatal infections. J. Med. Virol. 61, 481-487. doi: 10.1002/1096-9071(200008)61:4481::AID-JMV113.0.CO;2-H
77. Vanarsdall, A. L., Howard, P. W., Wisner, T. W., and Johnson, D. C. (2016). Human cytomegalovirus gH/gL forms a stable complex with the fusion protein gB in virions. PLoS Pathog. 12:e1005564. doi: 10.1371/journal.ppat.1005564
78. Vanarsdall, A. L., and Johnson, D. C. (2012). Human cytomegalovirus entry into cells. Curr. Opin. Virol. 2, 37-42. doi: 10.1016/j.coviro.2012.01.001
79. Vanarsdall, A. L., Ryckman, B. J., Chase, M. C., and Johnson, D. C. (2008). Human cytomegalovirus glycoproteins gB and gH/gL mediate epithelial cell-cell fusion when expressed either in cis or in trans. J. Virol. 82, 11837-11850. doi: 10.1128/JVI.01623-08
80. Varnum, S. M., Streblow, D. N., Monroe, M. E., Smith, P., Auberry, K. J., Paša-Tolic, L., et al. (2004). Identification of proteins in human cytomegalovirus (HCMV) Particles: the HCMV Proteome. J. Virol. 78, 10960-10966. doi: 10.1128/JVI.78.20.10960-10966.2004
81. Vey, M., Schäfer, W., Reis, B., Ohuchi, R., Britt, W., Garten, W., et al. (1995). Proteolytic processing of human cytomegalovirus glycoprotein B (gpUL55) is mediated by the human endoprotease furin. Virology 206, 746-749. doi: 10.1016/S0042-6822(95)80002-6
82. Vogel, J.-U., Otte, J., Koch, F., Gümbel, H., Doerr, H. W., and Cinatl, J. (2013). Role of human cytomegalovirus genotype polymorphisms in AIDS patients with cytomegalovirus retinitis. Med. Microbiol. Immunol. 202, 37-47. doi: 10.1007/s00430-012-0244-3
83. Wang, X., Huang, D. Y., Huong, S.-M., and Huang, E.-S. (2005). Integrin alphavbeta3 is a coreceptor for human cytomegalovirus. Nat. Med. 11, 515-521. doi: 10.1038/nm1236
84. Wu, K.-G., Hung, M.-C., Chang, Y.-T., Chen, C.-J., Yang, S.-P., Liu, C.-Y., et al. (2011). Occurrence of human cytomegalovirus glycoprotein B genotypes in immunocompetent and immunosuppressed Taiwanese patients. Intervirology 54, 196-201. doi: 10.1159/000322382
85. Wu, Y.-M., Yan, J., Ojcius, D. M., Chen, L.-L., Gu, Z.-Y., and Pan, J.-P. (2007). Correlation between Infections with different genotypes of human cytomegalovirus and Epstein-Barr Virus in subgingival samples and periodontal status of patients. J. Clin. Microbiol. 45, 3665-3670. doi: 10.1128/JCM.00374-07
86. Xia, C., Zhao, X., Sun, Y., and Zhang, Z. (2012). Human cytomegalovirus glycoprotein B genotypes in Chinese hematopoietic stem cell transplant recipients. Intervirology 55, 342-348. doi: 10.1159/000330303
87. Yamamoto, A. Y., Mussi-Pinhata, M. M., de Deus Wagatsuma, V. M., Marin, L. J., Duarte, G., and Figueiredo, L. T. M. (2007). Human cytomegalovirus glycoprotein B genotypes in Brazilian mothers and their congenitally infected infants. J. Med. Virol. 79, 1164-1168. doi: 10.1002/jmv
88. Yi, L., Wang, D.-X., and Feng, Z.-J. (2008). Detection of human cytomegalovirus in atherosclerotic carotid arteries in humans. J. Formos. Med. Assoc. 107, 774-781. doi: 10.1016/S0929-6646(08)60190-4
89. Zheng, S.-S., Zhou, L., Qian, J., Cai, T., Fan, J., and Ma, W.-H. (2002). Cytomegalovirus glycoprotein B sequence variation in Chinese liver transplant recipients. Hepatobiliary Pancreat. Dis. Int 1, 26-29.